Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio 2024-12-05 06:30
CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms 2024-12-04 22:26
Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer 2024-12-04 08:00
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow 2024-12-03 22:00
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong 2024-12-02 07:40
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China 2024-11-30 09:00
Microbio Appoints Paul Brennan as Chair of the Board 2024-11-29 06:30
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:30
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients 2024-11-28 17:22
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List 2024-11-28 16:59
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List 2024-11-28 13:43
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country 2024-11-28 13:04
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List 2024-11-28 12:07
Everest Medicines to Hold Investor Calls on Data Results from EVER001 Phase 1b/2a Clinical Study in Primary Membranous Nephropathy 2024-11-27 19:08
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC 2024-11-27 14:34
Exyte Receives Micron's Outstanding Supplier Performance Award in Supplier Diversity 2024-11-26 20:19
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology 2024-11-26 18:49
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC) 2024-11-26 17:16
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors 2024-11-25 08:37
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024 2024-11-25 08:30
1 2 3 4 5 233